Abbott LaboratoriesABT +3.49%76 Receivables Turnover is 1.38 as of Mar. 2026. GuruFocus rates ABT with a GF Score™ of 76/100 and a GF Value™ of $129.98 (Modestly Undervalued). Among 812 Medical Devices & Instruments companies, Abbott Laboratories ranks better than 52.09% on this metric.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Abbott Laboratories's Revenue for the
three
months ended in Mar. 2026 was $11,164 Mil. Abbott Laboratories's average Accounts Receivable for the
three
months ended in Mar. 2026 was $8,070 Mil.
Hence, Abbott Laboratories's Receivables Turnover for the
three
months ended in Mar. 2026 was 1.38.
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
Abbott Laboratories Receivables Turnover Related Terms
Abbott Laboratories Receivables Turnover Historical Data
* Premium members only.
The historical data trend for Abbott Laboratories's Receivables Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ABT vs SYK, MDT, BSX: Receivables Turnover Comparison
For the Medical Devices subindustry, Abbott Laboratories's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Abbott Laboratories Receivables Turnover vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Abbott Laboratories's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where Abbott Laboratories's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Abbott Laboratories (ABT) has a Receivables Turnover of 1.38 as of Mar. 2026. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Abbott Laboratories and its competitors. According to the industry distribution chart, Abbott Laboratories ranks #389 out of 812 companies in the Medical Devices & Instruments industry, placing it in the top 47.9%.
Is Abbott Laboratories' Receivables Turnover too high?
Abbott Laboratories' current Receivables Turnover is 1.38. The Medical Devices & Instruments industry median Receivables Turnover is 5.53. Abbott Laboratories' value of 1.38 is 75% below this industry median. Based on the distribution chart, Abbott Laboratories ranks #389 out of 812 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Abbott Laboratories has a GF Score™ of 76/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Abbott Laboratories' Receivables Turnover compare to SYK and MDT?
According to the Medical Devices & Instruments industry distribution chart, Abbott Laboratories ranks #389 out of 812 companies for Receivables Turnover. This puts Abbott Laboratories in the upper half of its industry. The industry median Receivables Turnover is 5.53. Abbott Laboratories' value of 1.38 is 75% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Medical Devices & Instruments company?
The median Receivables Turnover among Medical Devices & Instruments companies is 5.53, based on 812 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Abbott Laboratories's current Receivables Turnover of 1.38 is 75% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Abbott Laboratories and its competitors. For the Medical Devices & Instruments industry, the median Receivables Turnover is 5.53 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Abbott Laboratories's current Receivables Turnover is 1.38. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Abbott Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Abbott Laboratories (ABT) is currently considered Modestly Undervalued. The stock's GF Value™ is $129.98, compared to a current price of $95.40 — trading 26.6% below its estimated fair value. The current Receivables Turnover is 1.38 and 75% below the Medical Devices & Instruments industry median of 5.53. Abbott Laboratories' overall GF Score™ is 76/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For Abbott Laboratories (ABT), the current Receivables Turnover is 1.38 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Abbott Laboratories (ABT) Overvalued in 2026?
Based on GuruFocus' analysis, Abbott Laboratories stock appears to be undervalued.
The current stock price of $95.40 is trading 26.6% below its estimated GF Value™ of $129.98.
GuruFocus considers Abbott Laboratories to be Modestly Undervalued.
Key valuation signals for ABT:
Receivables Turnover: 1.38
GF Value™: $129.98 vs. price of $95.40 (26.6% below fair value)
Industry Position: 75% below the Medical Devices & Instruments median (#389 of 812)
No single metric tells the full story. See the ABT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.
76GF Score
Get the complete analysis for ABT
Receivables Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ABT has been successfully added to your 
